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SPECIAL  CWD  ISSUE 
 
The recent discovery of chronic wasting disease 
(CWD) in wild deer in new locations in 
Colorado, Nebraska, South Dakota, and 
Wisconsin has led to unprecedented attention 
and concern for a wildlife health issue.  A short 
list of CWD-related events in the last few 
months includes complete bans on live cervid 
importation in several states, management plans 
to kill as many wild cervids as possible in areas 
in Wisconsin and Colorado where CWD 
recently was found, depopulation of captive elk 
herds in the CWD endemic area of northeastern 
Colorado, and a congressional hearing on CWD.  
A joint CWD Task Force co-chaired by the 
Administrator of USDA's Animal Plant and 
Health Inspection Service (APHIS) and the 
Director of the U.S. Fish and Wildlife Service 
was formed in mid-May.  Within this task force, 
six working groups have been directed to 
develop a 5-year national management plan for 
CWD. 
 
News about CWD now comes to wildlife 
management and animal health authorities on a 
daily basis and it has become challenging to stay 
informed about this rapidly evolving situation.  
The purpose of this special issue of the SCWDS 
BRIEFS is to provide historical and up-to-date 
facts about CWD and other transmissible 
spongiform encephalopathies.  Several persons 
assisted with this special issue, and we are 
grateful to them: Lynn Creekmore, Linda 
Detwiler, Lisa Ferguson, and Tom Gomez with 
USDA-APHIS; Bruce Morrison of the Nebraska 
Game and Parks Commission; Ron Fowler of 
the South Dakota Department of Game, Fish, 
and Parks; and Beth Williams of the University 
of Wyoming.  Additional sources of 
information, including scientific articles, book 
chapters, and agency websites, are listed for 
further reading.  Updates on CWD and other 
wildlife health topics will be provided in future 
issues of the SCWDS BRIEFS. 
 
Transmissible Spongiform Encephalopathies 
 
Transmissible spongiform encephalopathies 
(TSEs) are invariably fatal diseases of the 
central nervous system that occur in domestic 
and wild animals and humans.  TSEs in 
domestic animals include scrapie of sheep and 
goats, transmissible mink encephalopathy 
(TME), and bovine spongiform encephalopathy 
(BSE, also known as mad cow disease).  
Chronic wasting disease (CWD) is the only TSE 
currently found in free-ranging wildlife (white-
tailed deer, mule deer, and elk), and it also has 
been found in captive animals of like species.  
Human TSEs include Creuzfeldt-Jakob disease 
(CJD), new variant CJD, kuru, Gerstmann-
Straussler-Scheinker syndrome, and fatal 
familial insomnia.  
 
Although each of these TSEs is considered 
different, they all share important characteristics 
and thus are grouped together.  Scientific debate 
continues about the cause of TSEs, but all are 
thought to be caused by the same type of 
infectious agent.  The most widely accepted 
theory describes TSE agents as abnormal, 
proteinaceous, infectious particles (prions) that 
are closely related to a cell protein normally 
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produced in the central nervous system, 
lymphoid tissue, and many other body tissues.  
However, abnormal TSE prions cannot be 
broken down by the body’s enzyme protease.  
Researchers call the normal form of the cell 
protein PrPc, whereas the enzyme-resistant form 
is shaped differently and is generically known 
as PrPres.  Following introduction into the body, 
PrPres promotes conversion of normal PrPc to 
more of the undegradable PrPres in lymphoid 
tissues and brain cells.  The end result is a 
pathologic accumulation of PrPres in brain cells 
that results in nerve cell death and loss of 
neurologic function.  Two unique aspects of 
PrPres include lack of genetic material (DNA or 
RNA) and extreme resistance to breakdown by 
environmental conditions, disinfectants, and 
treatments that normally inactivate infectious 
disease agents such as viruses, bacteria, fungi, 
etc.  All TSEs are characterized by long 
incubation periods, ranging up to several years, 
and currently there are no treatments or 
vaccines.   
 
There are several ways that TSEs can develop.  
In human beings, sporadic TSEs may develop 
when some of the person’s normal prions (PrPc) 
spontaneously change into PrPres thereby 
altering the person’s normal PrPc in a chain 
reaction.  Inherited cases occur in people who 
receive a defective gene that codes for the PrPc 
protein, causing it to be shaped abnormally.  
Finally, acquired cases may arise when PrPres 
from an affected individual is transferred to 
another through contact with infected central 
nervous system tissue or contaminated medical 
instruments.  In animals, TSEs are acquired; the 
spontaneous or inherited forms have not been 
found, although they may occur. Studies in 
animals reveal that after PrPres is ingested, the 
disease agent spreads from the gastrointestinal 
tract to the spinal cord and brain.  There is no 
apparent immune response to the disease agent 
and inflammation is not seen in affected tissues. 
All TSEs of domestic and wild animals and 
humans have characteristic damage to brain 
cells (neurons) that results in a spongiform 
degenerative change in the gray matter when the 
brain is examined microscopically, thus the term 
“spongiform encephalopathy.”  PrPres can be 
detected in affected brain tissue and also in 
normal-appearing lymphoid cells of infected 
hosts with certain TSEs such as scrapie and 
CWD. The latter feature may prove useful for 
diagnosis via detection of the TSE agent.  The 
distribution of PrPres is very limited with other 
TSEs, such as BSE.  (Prepared by Nicole 
Gottdenker and Vic Nettles). 
 
Additional sources of information: 
 
Williams, Elizabeth S., Michael W. Miller, and 
E. Tom Thorne.  Chronic Wasting Disease:  
Implications and Challenges for Wildlife 
Managers.   Transactions of the 67th North 
American Wildlife and Natural Resources 
Conference.  In Press. 
 
Centers for Disease Control and Prevention 
(www.cdc.gov)  
 
National Institutes of Neurological Disorders 
and Stroke (www.ninds.nih.gov) 
 
USDA's Animal and Plant Health Inspection 
Service (www.aphis.usda.gov) 
 
TSEs of Domestic Animals and Humans  
 
The earliest historical records of transmissible 
spongiform encephalopathies (TSEs) began with 
sheep scrapie more than 250 years ago in 
England.  Microscopic brain lesions of scrapie 
were described in the 19th century, and its 
transmissible nature and long incubation period 
were demonstrated experimentally in the 1930s.  
The scrapie agent is thought to spread from 
animal to animal, primarily from an infected 
ewe to her offspring, and to other lambs through 
contact with the placenta or placental fluids.  
Clinical signs usually appear between 2 and 5 
years after infection but may not occur until 
much later.  Affected sheep and goats show 
progressive neurologic disease, including 
behavioral changes, head and neck tremors, 
ataxia, and self-trauma due to incessant itching.  
Death typically occurs within 1 to 6 months or 
longer after the onset of clinical signs.  In the 
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United States, scrapie was first diagnosed in 
1947 in a flock that had received sheep of 
British origin.  Scrapie has been identified in 
more than 1,000 flocks in the United States, and 
currently it is the target of an eradication 
program administered by the USDA’s Animal 
and Plant Health Inspection Service.  There is 
no evidence to indicate that scrapie poses a risk 
to human health. 
 
A few outbreaks of transmissible mink 
encephalopathy (TME) have been reported in 
ranched mink in Europe and North America.  
This rare TSE has never been found in wild 
mink.  Outbreaks are believed to be caused by 
exposure to the infectious agent, such as by 
eating contaminated feed, and are characterized 
by 60% to 100% morbidity within a ranched 
mink population and 100% mortality of affected 
mink.  Affected animals initially show 
behavioral changes, aggression, and ataxia; later 
they become moribund and die.  Although TME 
is not a significant disease of domestic animals 
or humans, it has great utility as an experimental 
TSE model.  
 
Several TSEs occur in humans.  Kuru is a TSE 
of the Fore natives of the highlands of New 
Guinea who performed ritual cannibalism of 
relatives after natural death.  Kuru essentially 
has disappeared since mortuary cannibalism 
practices were discontinued.  Gerstmann-
Straussler-Scheinker Syndrome and fatal 
familial insomnia are extremely rare hereditary 
TSEs that have been demonstrated to be 
transmissible under laboratory conditions.  They 
are found in just a few families around the 
world.  Although quite rare, the most common 
TSE in humans is classic Creutzfeldt-Jakob 
Disease (CJD), with a worldwide incidence of 
approximately one case per one million people 
per year.  Disease usually develops later in life; 
the typical age of onset is around 60 years.  As 
with all TSEs, CJD is characterized by 
progressive neurological disease that is 
invariably fatal.  
 
In 1996, researchers recognized a “new variant” 
of Creutzfeldt-Jakob Disease (vCJD) in British 
people.  The most likely explanation of this new 
form of the disease was exposure to the BSE 
agent.  Additional research since that time has 
found epidemiological and laboratory evidence 
to further support the causal association between 
BSE and vCJD, thus linking vCJD with 
consumption of products contaminated with 
central nervous system tissue of cattle with 
BSE.  BSE is the only TSE of domestic or wild 
animals ever linked with human disease.  
Human patients with vCJD generally were much 
younger at the age of death (median age of 28) 
than victims of sporadic CJD (median age of 
68), and the microscopic features of vCJD 
differed from classic CJD.  Since it was first 
recognized, vCJD has been documented as the 
definite or probable cause of death or disease of 
130 people in the United Kingdom (121), 
France (6), Ireland (1), Italy (1), and the United 
States (1).  The single probable case in the 
United States was reported in April 2002 in a 
young woman who had come to the United 
States after spending much of her life in the 
United Kingdom.  There never has been a case 
of vCJD that did not have a history of exposure 
within a country where BSE was occurring.  
The epidemiological and laboratory evidence 
linking BSE and vCJD is very strong and a 
cause of concern among public health officials, 
citizens, and meat industries of Great Britain 
and other countries around the world.   
 
Bovine spongiform encephalopathy (BSE) was 
recognized in the mid-1980s in cattle in Great 
Britain.  BSE is covered at length in the 
following article.  (Prepared by Nicole 
Gottdenker and John Fischer) 
 
Additional sources of information: 
 
Williams, Elizabeth S., Michael W. Miller, and 
E. Tom Thorne.  Chronic Wasting Disease:  
Implications and Challenges for Wildlife 
Managers.   Transactions of the 67th North 
American Wildlife and Natural Resources 
Conference.  In Press. 
 
Centers for Disease Control and Prevention 
(www.cdc.gov)  
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National Institutes of Neurological Disorders 
and Stroke (www.ninds.nih.gov) 
 
UK CJD Surveillance Unit (www.cjd.ed.ac.uk) 
 
USDA's Animal and Plant Health Inspection 
Service (www.aphis.usda.gov) 
 
Bovine Spongiform Encephalopathy 
 
Since 1986, more than 180,000 cases of bovine 
spongiform encephalopathy (BSE), also known 
as mad cow disease, have been reported in 
numerous European countries and Japan, with 
more than 95% of the cases occurring in Great 
Britain.  Neither BSE nor any other 
transmissible spongiform encephalopathies 
(TSEs) have been detected in cattle in the 
United States, despite more than 12 years of 
active surveillance.   The British BSE epidemic 
apparently arose through the feeding of 
ruminant-derived protein contaminated with a 
TSE agent suspected to be a strain of sheep 
scrapie or a previously unrecognized TSE in 
cattle.  The epidemic was sustained and boosted 
by recycling of BSE infected cattle to other 
cattle via feeds containing ruminant meat and 
bone meal.  Epidemiological studies suggest 
widespread exposure of British cattle via 
contaminated commercial feed as early as 1980, 
and it is believed that changes in rendering 
procedures in the 1970s and 1980s resulted in 
failure to inactivate the TSE agent.  
Transmission of BSE is primarily, if not solely, 
through this contaminated feed route as 
additional studies indicate that there has been 
little or no horizontal spread from animal to 
animal, as occurs with scrapie and chronic 
wasting disease.  In Great Britain, the BSE 
epidemic peaked in early 1993 with an 
incidence of more than 1,000 new cases per 
week.   As a result of feed bans initiated in 
1988, the incidence has dropped markedly and 
currently runs about 25 new cases per week.  
 
Transmissible spongiform encephalopathies 
have affected other species, including domestic 
and exotic cats, in which it is known as Feline 
Spongiform Encephalopathy (FSE), as well as 
exotic ruminants in zoological collections.  BSE 
is believed to have affected 10 bovid and felid 
species from zoos in the British Isles, viz.,  
eland, greater kudu, nyala, oryx, gemsbock, 
bison, cougar, ocelot, tiger, and cheetah.  The 
agent isolated from several of these cases of 
FSE and the TSE of exotic ruminants is 
indistinguishable from BSE in cattle using strain 
typing in mice, suggesting the occurrence of 
TSEs in these species resulted from BSE-
contaminated feed.  
 
Without doubt, the great publicity and concern 
surrounding BSE is due to its epidemiological 
and laboratory-supported link with new variant 
CJD (vCJD) in humans.  This new human TSE 
was first recognized in Great Britain in 1996 
and appears to be associated with the 
consumption of BSE-infected cattle products, 
specifically beef products contaminated with 
central nervous system tissue containing the 
BSE agent.  To date, there have been 130 
definite or probable cases of vCJD in humans.  
Although there is strong evidence that the BSE 
agent is responsible for vCJD cases, the specific 
foods possibly associated with transmission to 
humans are unknown.  In cattle experimentally 
infected by the oral route, the BSE agent has 
been identified in brain, spinal cord, retina, 
nerve roots near the vertebrae, and bone 
marrow.  In naturally infected cattle, the agent 
has been found only in brain, spinal cord, and 
retina.  
 
Control measures for BSE in the United 
Kingdom and other affected countries include 
bans on animal-derived proteins in livestock 
feeds; prohibitions on the use of specified risk 
materials in any food, feed, or biological 
product; culling of cattle at highest risk of 
infection; and stringent regulations or bans on 
the movement of animals and animal products.  
Countries without BSE have employed import 
restrictions and similar measures to prevent its 
introduction and spread. 
 
Since 1989, the United States has banned 
importation of ruminants and most ruminant 
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products from countries identified as having 
BSE or at risk for having BSE.  Cattle imported 
from high-risk countries prior to the ban have 
been euthanized and tested for BSE or have 
been quarantined and monitored.  There is a 
U.S. ban on the importation of processed animal 
protein products, regardless of species, from 
BSE-restricted countries.  Since 1997, the U.S. 
Food and Drug Administration (FDA) has 
banned the use of most mammalian protein in 
ruminant feeds and has issued guidelines 
concerning the use of bovine materials from 
BSE-restricted countries in human medical 
products.  Since 1990, the USDA’s Animal and 
Plant Health Inspection Service (APHIS) has 
conducted an active surveillance program for 
BSE.  Samples are obtained from the target 
high-risk population -- adult cattle that exhibit 
neurological signs, non-ambulatory ("downer") 
cows, and animals that die of unknown causes.  
More than 26,000 animals in the United States 
have been tested for BSE to date with uniformly 
negative results.   
 
In 1998, the USDA entered into a cooperative 
agreement with Harvard University's School of 
Public Health to conduct an analysis and 
evaluation of potential pathways for BSE to 
enter the U.S. national cattle herd or food 
supply.  Harvard assessed the pathways by 
which BSE could potentially occur in the United 
States, pathways by which humans could 
potentially be exposed to the BSE agent from 
beef products, and identified additional 
measures that could be taken to protect human 
and animal health in the United States.  The 
results of this analysis, made public in 
November 2001, found that the United States is 
highly resistant to the introduction and spread of 
the BSE agent in the U.S. cattle herd due to 
existing federal regulatory programs.  The 
measure identified as most effective in reducing 
the spread of BSE is the ban instituted by FDA 
to prevent recycling of potentially infectious 
cattle tissues.  (Prepared by John Fischer) 
 
Additional sources of information: 
 
Centers for Disease Control and Prevention 
(www.cdc.gov) 
 
United Kingdom's Department for Environment, 
Food, and Rural Affairs (www.defra.gov.uk) 
 
USDA's Animal and Plant Health Inspection 
Service (www.aphis.usda.gov) 
 
Chronic Wasting Disease 101 
 
Concern about chronic wasting disease (CWD) 
is increasing for wildlife managers, animal 
health authorities, captive cervid owners, and 
the public across North America.  Many 
biological features of CWD pose significant 
challenges for those attempting to control or 
eradicate the disease.  Perhaps even greater 
challenges are those associated with balancing 
complex and often competing and conflicting 
interests of the general public, sportsmen, the 
game farming industry, traditional livestock 
industries, and many state and federal animal 
health and public health agencies.  
 
Chronic wasting disease was first recognized in 
the 1960s as a syndrome of captive mule deer 
held in several wildlife research facilities in Ft. 
Collins, Colorado.  Originally believed to be a 
nutritional malady, CWD was not recognized as 
a transmissible spongiform encephalopathy 
(TSE) until 1978.  CWD soon was identified in 
captive deer and elk from other wildlife research 
facilities near Kremmling and Meeker Colorado,  
and at Wheatland, Wyoming, as well as in at 
least two zoological collections.  By the 1980s, 
CWD had been documented in free-ranging deer 
and elk in northeastern Colorado/southeastern 
Wyoming, and active surveillance in 2000 
revealed that this endemic area extended into 
adjacent western Nebraska.  From 1996 through 
early 2002, CWD has been diagnosed in 
privately owned captive elk herds in Colorado, 
Kansas, Montana, Nebraska, Oklahoma, South 
Dakota, and the Canadian provinces of Alberta 
and Saskatchewan.  From late 2000 to April 
2002, CWD also has been detected in wild deer 
at locations in northwestern Nebraska, 
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Saskatchewan, South Dakota, Wisconsin, and 
on the Western Slope of Colorado. 
 
The origin of CWD is unknown, and it may 
never be possible to definitively determine how 
or when CWD arose.  It is possible that CWD 
was derived from scrapie, a TSE of domestic 
sheep recognized in the United States since 
1947.  Arguments can be made both for and 
against this hypothesis.  It also is possible that 
CWD is a spontaneous TSE that arose in deer in 
the wild or in captivity and has biological 
features promoting transmission to other deer 
and elk.  The majority of cases of the human 
TSE Creutzfeldt-Jakob Disease (CJD) are 
thought to be spontaneous.  Occurrence of 
spontaneous CJD is approximately one case per 
one million humans per year.  It is possible, but 
difficult, to prove that spontaneous CWD may 
have occurred in deer.   
 
Only three species of the family Cervidae are 
known to be naturally susceptible to CWD:  
mule deer (Odocoileus hemionus), white-tailed 
deer (Odocoileus virginianus), and Rocky 
Mountain elk (Cervus elaphus nelsoni), though 
it is very likely that other subspecies of C. 
elaphus are susceptible.  Susceptibility of other 
cervid species to CWD is not known.  Cattle and 
other domestic livestock appear to be resistant 
to natural infection; to date, only 3 of 13 cattle 
have become infected with the CWD agent 
following experimental intracerebral 
inoculation, although this and other 
experimental studies begun in 1997 are not yet 
completed. 
 
Chronic wasting disease-affected deer and elk 
show loss of body condition and changes in 
behavior.  The clinical disease often is more 
subtle and prolonged in elk than in deer.  
Affected animals may walk repetitive courses; 
show subtle ataxia and a wide-based stance; 
have subtle head tremors;  be found near water 
sources or in riparian areas; have periods of 
somnolence; and may carry their head and ears 
lowered.  Chronic wasting disease-affected 
animals continue to eat, but amounts of feed 
consumed are reduced, leading to gradual loss 
of body condition.  Excessive drinking, 
urination, salivation, and drooling are common 
in the terminal stages.  Death is inevitable once 
clinical disease occurs. 
 
The clinical course of CWD varies from a few 
days to approximately a year, with most animals 
surviving from a few weeks to several months 
after onset of signs.  While a protracted clinical 
course is typical, occasionally acute death may 
occur.  This may be more common in the wild 
than in the relative security of captivity.   
Aspiration pneumonia is a common finding at 
postmortem examination of terminal CWD 
cases and presumably is due to difficulty 
swallowing, hypersalivation, and inhalation of 
foreign material into the lungs. Thus the brain 
should be examined for evidence of CWD on 
every prime age cervid that dies with 
pneumonia.  (Excerpted and modified from:  
Williams, Elizabeth S., Michael W. Miller, and 
E. Tom Thorne.  Chronic Wasting Disease:  
Implications and Challenges for Wildlife 
Managers.   Transactions of the 67th North 
American Wildlife and Natural Resources 
Conference.  In Press.) 
 
CWD Epidemiology 
 
Chronic wasting disease (CWD) is both 
transmissible and infectious, but many details of 
its transmission remain to be determined.  In 
contrast to bovine spongiform encephalopathy 
(BSE), CWD is not a foodborne disease 
associated with rendered ruminant meat and 
bonemeal.  Instead, observations of CWD 
among captive deer and elk provide strong 
evidence of lateral transmission, which is more 
similar to scrapie of sheep and goats.  
Experimental and epidemic modeling data 
support these anecdotal observations.  Maternal 
transmission may occur but appears to be 
relatively rare.  Some interspecies transmission 
probably occurs among the three natural host 
species.  Apparent transmission from mule deer 
to elk, mule deer to white-tailed deer, and elk to 
mule deer and white-tailed deer has been 
observed. 
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The presumed CWD agent has been 
demonstrated by special procedures in various 
lymphoid tissues, including those of the 
digestive tract (e.g., tonsil, Peyer’s patches, and 
mesenteric lymph nodes). These distribution 
patterns suggest that the agent may be shed 
through the alimentary tract.  Because TSE 
agents are extremely resistant in the 
environment, transmission may be both direct 
and indirect. Concentrating deer and elk in 
captivity or by artificial feeding probably 
increases the likelihood of direct and indirect 
transmission between individuals.  
Contaminated pastures appear to have served as 
sources of infection in some CWD epidemics; 
similar phenomena have been suspected in some 
outbreaks of sheep scrapie.  The apparent 
persistence of the CWD agent in contaminated 
environments represents a significant obstacle to 
eradication of the disease from either farmed or 
free-ranging cervid populations. 
 
The overall duration of CWD infection (time 
from exposure to end-stage clinical disease) has 
been difficult to determine in natural cases.  
Without clear knowledge of when animals 
become infected, it is impossible to accurately 
determine the overall course of disease.  
Experimental CWD challenge studies based on 
single-dose oral exposure to infectious brain 
tissue have yielded some insights into the 
disease course; however, experimental data 
probably underestimate time frames for natural 
infections.  Experimentally, minimum 
incubation time was about 15 months, and mean 
time from oral infection to death was about 23 
months (range 20 to 25 months) in mule deer.  
The range of incubation observed in orally 
infected elk was approximately 12 to 34 months.  
The maximum disease course is not known, but 
can exceed 25 months in experimentally 
infected deer and 34 months in elk.  Duration is 
less certain in naturally occurring cases.  The 
youngest animal diagnosed with clinical CWD 
was 17 months old, suggesting 16 to 17 months 
may be the minimum natural incubation period.  
Among deer and elk residing in facilities with a 
long history of CWD, most natural cases occur 
in 2- to 7-year-old animals; however, deer have 
lived more than 7 years in heavily infected 
facilities without succumbing to CWD, and elk 
more than 15 years of age have succumbed to 
CWD. It is not known when during the course 
of infection an animal may become infectious, 
but it appears likely that shedding of the CWD 
agent is progressive through the disease course; 
epidemic models suggest shedding probably 
precedes onset of clinical disease in both deer 
and elk. 
 
Chronic wasting disease can reach remarkably 
high prevalence in captive cervid populations. 
In one infected research facility, more than 90% 
of mule deer resident for more than 2 years died 
or were euthanized while suffering from CWD.  
Recently, high CWD prevalence (about 50%) 
has been demonstrated in white-tailed deer 
confined in association with an infected 
Nebraska elk farm.  Among captive elk, CWD 
was the primary cause of adult mortality (5 of 7, 
71%; 4 of 23, 23%) in 2 research herds, and 
high prevalence (59%) was detected in a group 
of 17 elk slaughtered from an infected farm 
herd. 
 
To estimate prevalence in infected free-ranging 
populations, tissues from deer and elk harvested 
by hunters in CWD-endemic areas have been 
collected and examined at random.  Within 
endemic areas, prevalence of preclinical CWD 
has been estimated at less than 1% in elk and 
less than 1% to 15% in mule deer.  Modeled 
CWD epidemics failed to achieve a steady-state 
equilibrium in infected deer populations, 
suggesting that CWD may lead to local 
extirpations of infected deer populations if left 
unmanaged.  (Excerpted and modified from:  
Williams, Elizabeth S., Michael W. Miller, and 
E. Tom Thorne.  Chronic Wasting Disease:  
Implications and Challenges for Wildlife 
Managers.   Transactions of the 67th North 
American Wildlife and Natural Resources 
Conference.  In Press.) 
 
CWD Diagnosis 
 
Chronic wasting disease (CWD) cannot be 
diagnosed on the basis of clinical signs, because 
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several neurological diseases and other maladies 
may produce similar physical or behavioral 
abnormalities in deer and elk.  Currently there is 
no approved live animal test for CWD, and the 
diagnosis is made by postmortem microscopic 
examination of brain for lesions (spongiform 
change with degeneration and loss of neurons) 
and/or for accumulation of abnormal prions 
(PrPCWD), the presumed causative agent of 
CWD. 
 
Microscopic lesions are apparent only after the 
onset of clinical disease in deer and elk, but 
PrPCWD accumulation can be detected in animals 
before clinical signs develop.  Although there is 
widespread PrPCWD accumulation in the brain 
later in the course of infection when clinical 
signs are apparent, early accumulation of 
PrPCWD is known to occur only in a very 
specific site in clinically normal animals.  This 
site is located in the medulla oblongata of the 
brainstem directly beneath the cerebellum.  
With practice, this portion of the brainstem can 
easily be removed and preserved in formalin for 
testing.  Immunohistochemical  (IHC) staining 
of this area is used to demonstrate the presence 
or absence of PrPCWD, and currently it is 
regarded as the only meaningful test for 
clinically normal animals.  A positive IHC 
result, with or without spongiform lesions, is 
sufficient to diagnose CWD infection.  In some 
cases, supplementary tests may be employed to 
confirm a positive IHC result.   
 
Recent investigations have demonstrated a 
potential live animal test for CWD in mule deer.  
The procedure involves IHC staining for PrPCWD 
within lymphoid tissue obtained via tonsil 
biopsy.  Studies have shown that PrPCWD 
accumulates in lymph nodes and tonsil of mule 
deer early during CWD incubation.  Although 
useful in special situations for mule deer and 
potentially of use in whitetails, the tonsil test 
does not appear to be of use for antemortem 
CWD testing of elk, due to differences in CWD 
pathogenesis in this species.  Furthermore, there 
is little chance that this live animal test would 
have much application on a large scale in wild 
populations, because individual animals would 
have to be captured and anesthetized for the 
biopsy procedure.  If test results are positive, the 
animal would then have to be located and 
euthanized in most CWD control programs.  
Several other diagnostic tests for transmissible 
spongiform encephalopathies in other species, 
including BSE in cattle and scrapie in sheep, are 
being evaluated for potential use in CWD 
diagnostic testing of deer and elk.  Some of 
these tests, if validated, may provide more rapid 
testing than current IHC procedures. (Prepared 
by Rick Gerhold) 
 
Additional information: 
Williams, Elizabeth S., Michael W. Miller, and 
E. Tom Thorne.  Chronic Wasting Disease:  
Implications and Challenges for Wildlife 
Managers.  Transactions of the 67th North 
American Wildlife and Natural Resources 
Conference.  In Press.   
 
CWD Surveillance, Doing the  Numbers 
 
The known distribution of chronic wasting 
disease (CWD) has expanded at an alarming 
rate in the past 2 years, and there will be 
increasing pressure on wildlife managers to 
evaluate the status of deer and elk populations 
under their authority.  Unfortunately, detection 
of CWD or confirmation that the disease is not 
present will require both hard work and money.  
The primary test currently available for CWD 
requires brain tissue from deer or elk, and 
laboratory costs alone are $20 or greater per 
animal.  The funds necessary to collect and test 
the number of  samples required to reach a 
defendable position on the absence of CWD in a 
deer or elk herd will strain wildlife agency 
budgets, and the flood of samples will 
overwhelm existing laboratory capabilities 
nationwide. 
 
How to look for CWD is no simple matter.  
Presently, the two surveillance strategies 
generally used are: (1) testing of sick or "target 
animals" discovered or reported to wildlife 
agencies (a passive surveillance system) or (2) 
conducting random surveys of normal deer or 
elk killed by hunters or agency personnel (an 
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active surveillance system).  CWD “target” 
animals are defined as deer or elk of 18 months 
of age or older that are emaciated and showing 
some combination of signs including abnormal 
behavior, increased salivation, tremors, 
stumbling, incoordination, difficulty 
swallowing, excessive thirst, and excessive 
urination.  Perhaps it would be better to simplify 
the definition to include sick-appearing deer or 
elk that are emaciated or have neurologic 
disorders. 
 
The best epidemiological information available 
on CWD in wild populations comes from the 
long-term study of deer and elk in the endemic 
area in northeastern Colorado and southeastern 
Wyoming.  A crucial fact from this study is low 
prevalence of CWD infection found in the wild.  
Overall, prevalence rates in the endemic zone 
were 4.7% for mule deer, 2% for white-tailed 
deer, and 0.5% for elk, although there were “hot 
spots” within the study area that ran as high as 
15% in mule deer.  Unfortunately, what this 
means for wildlife biologists is that sample sizes 
in active surveillance programs must be massive 
before any credence can be given to negative 
results.  Thus, costs of active surveillance are 
going to be high. 
 
In contrast, when the aforementioned 
researchers evaluated their success in 
diagnosing CWD from clinically ill (target) deer 
and elk in the endemic area, their overall case 
positive rates were 57%, 35%, and 44% for 
mule deer, white-tailed deer, and elk, 
respectively.  They concluded that “targeted 
surveillance appears to be an effective strategy 
for detecting new CWD foci.”  However, it also 
was concluded that the first clinically ill animals 
were not apparent in various management units 
until the prevalence rate was about 1%.  
Furthermore, the numbers of sick deer 
submitted from a given management unit did 
not correspond with the prevalence rate 
determined by random sampling of that area.  
They found that the success of targeted 
surveillance was tied to human activity in the 
area and the level of concern about the disease. 
 
For the past 4 years, SCWDS has sent a 
surveillance questionnaire to wildlife 
management agencies and veterinary diagnostic 
laboratories seeking reports of target deer and 
elk that were examined for CWD.  We believe 
that the questionnaires are stimulating increased 
attention in regard to CWD; however, they 
revealed marked inconsistencies among states in 
the detection of  "target animals."   This was 
best exemplified by numerous states indicating 
that no target animals were identified over the 
course of a year or more.  "Targeted 
surveillance" is a passive system that relies 
heavily on the public reporting sick animals to 
appropriate agency personnel and then on 
follow-up action to acquire and test samples.  
The aim of targeted surveillance is to locate and 
test the animals most likely to be infected, 
thereby reducing surveillance costs, while at the 
same time enabling coverage of a large 
geographic area.   
 
Given the expanding concern about CWD, and 
the very real threat CWD poses to native 
cervids, wildlife managers can no longer afford 
to be casual about the discovery of any sick deer 
or elk.  It is imperative that these animals are 
obtained and tested for CWD.  Furthermore, 
given that active surveillance has been the 
method by which CWD has been detected 
among wild deer in several new locations 
including Saskatchewan, Nebraska, South 
Dakota, and Wisconsin, it is becoming clear that 
both surveillance methods should be strongly 
considered by wildlife management agencies.  
(Prepared by Vic Nettles) 
 
Additional Information: 
 
Miller, Michael W., et al.  2000.  Epizootiology 
of chronic wasting disease in free-ranging 
cervids in Colorado and Wyoming.  Journal of 
Wildlife Diseases 36(4): 676-690. 
 
CWD Management 
 
There is no treatment or vaccine for chronic 
wasting disease (CWD).  Once clinical signs 
develop, CWD is invariably fatal.  Furthermore, 
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long incubation periods, subtle early clinical 
signs, absence of a reliable live animal test, 
extremely resistant infectious agent, possible 
environmental contamination, and incomplete 
understanding of transmission all limit options 
for controlling or eradicating CWD. 
 
In captive facilities, management options 
currently are limited to quarantine or 
depopulation of CWD-infected herds.  Two 
attempts to eradicate CWD from cervid research 
facilities failed.  The causes of these failures 
were not determined, but residual environmental 
contamination following depopulation and/or 
facility clean-up was likely in both cases.  
Attempts to eliminate CWD from farmed elk 
populations are more recent, and consequently 
the efficacy of these attempts remains uncertain.  
Whether contaminated environments can ever 
be completely disinfected remains questionable.  
Until effective cleaning and disinfection 
procedures are identified, a very conservative 
approach must be taken when considering 
reintroduction of captive cervids into 
commercial facilities where CWD has occurred; 
moreover, free-ranging cervids also should be 
excluded from previously infected premises.  
Inherent difficulties in managing infected 
captive herds and premises underscore the need 
for aggressive surveillance to prevent 
movements of infected animals in commerce. 
 
Managing CWD in free-ranging animals 
presents even greater challenges.  Long-term, 
active surveillance programs to monitor CWD 
distribution and prevalence have been instituted 
in the endemic area in Colorado, Nebraska, and 
Wyoming to determine its extent and to assist in 
evaluating both temporal changes and effects of 
management intervention.  Management 
programs established to date focus on 
containing CWD and reducing its prevalence in 
localized areas.  Ultimate management goals 
vary among affected states and provinces.  In 
Nebraska, Wisconsin, Saskatchewan, and on 
Colorado's Western Slope where CWD may not 
yet be endemic, eradication is the stated goal for 
CWD management.  In contrast, wildlife 
managers in the CWD endemic area in Colorado 
and Wyoming have refrained from committing 
to eradication because it appears unattainable in 
their situations. 
 
A variety of specific strategies for managing 
CWD in free-ranging wildlife have been 
adopted in affected jurisdictions.  Translocating 
and artificially feeding cervids in endemic areas 
have been banned in attempts to limit range 
expansion and decrease transmission.  Selective 
culling of clinical suspects has been practiced 
throughout the endemic area of Colorado and 
Wyoming for a number of years, but this 
approach alone is insufficient to reduce 
prevalence in affected populations.  Localized 
population reduction in an area of high CWD 
prevalence has been undertaken in Colorado as 
a management experiment, but efficacy remains 
to be determined.  Although it seems intuitive 
that lowered deer and elk densities should 
reduce both transmission and likelihood of 
emigration of infected animals to adjacent areas, 
historic migration patterns and social behaviors 
characteristic of some deer and elk populations 
may diminish the effectiveness of wholesale 
density reduction in controlling CWD.  
 
Computerized epidemiologic modeling indicates 
that early and aggressive intervention through 
population reduction offers the best chance to 
prevent establishment of new endemic foci.  
Unfortunately, surveillance limitations (both 
cost and sensitivity) may delay detection of 
newly infected free-ranging populations for 
years after CWD has been introduced.  In 
Nebraska, Saskatchewan, Wisconsin, and on 
Colorado's Western Slope, aggressive 
reductions of deer numbers in newly identified 
positive locations are underway or planned in 
attempts to eliminate CWD from these areas.  
The recent development of tonsil biopsy as a 
live animal test for CWD in deer might aid 
control efforts under some special conditions, 
but large-scale applications to free-ranging 
populations seem impractical. 
 
Where it occurs, CWD in captive and free-
ranging cervids presents serious management 
problems.  Captive populations are quarantined, 
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thus limiting use and value of infected or 
exposed animals. Indemnity for depopulated 
cervids has been made available only recently in 
the United States.  In Canada, the magnitude of 
infection in farmed elk herds detected thus far 
has cost the Canadian government over 
$19,000,000 in indemnity and cleanup funds.  
Guidelines for management of captive herds 
with CWD are being developed by state and 
provincial animal health officials.  A national 
program is nearing adoption in Canada, and a 
similar program currently is under review in the 
United States.  Spillover of CWD into local 
free-ranging cervid populations may have 
occurred in two locations; further spillover 
could establish more endemic foci, thereby 
impairing long-term viability of both cervid 
farming and wildlife management in those 
areas. 
 
Implications for management of free-ranging 
populations of deer and elk may be even more 
significant.  Agencies do not translocate deer 
and elk from CWD endemic areas.  Ongoing 
surveillance programs are expensive and draw 
resources from other wildlife management 
needs.  Perhaps most important, impacts of 
CWD on population dynamics of deer and elk 
are presently unknown.  Modeling suggests that 
CWD could substantially harm infected cervid 
populations by lowering adult survival rates and 
destabilizing long-term population dynamics.  
Ultimately, public and agency concerns and 
perceptions about human health risks associated 
with all transmissible spongiform 
encephalopathies may erode participation in 
sport hunting in the endemic area and also may 
have dramatic influence on management of free-
ranging cervid herds where CWD is endemic.  It 
follows that wildlife management and animal 
health agencies should continue working to 
understand, prevent introduction, and limit the 
distribution and occurrence of CWD in free-
ranging and farmed cervids.  (Excerpted and 
modified from:  Williams, Elizabeth S., Michael 
W. Miller, and E. Tom Thorne.  Chronic 
Wasting Disease:  Implications and Challenges 
for Wildlife Managers.   Transactions of the 
67th North American Wildlife and Natural 
Resources Conference.  In Press.) 
 
CWD in Captive Cervids  
 
Although chronic wasting disease (CWD) was 
recognized in captive deer held in publicly 
owned research facilities in Colorado in the 
1960s, it was not detected in privately owned 
commercial cervids until 1996 in Saskatchewan.  
Since then, 1 or more cases of CWD have been 
confirmed in elk in 39 captive herds in 
Saskatchewan.  Primary or secondary 
epidemiological links have been found between 
every infected herd and a single source herd in 
the province that apparently imported infected 
elk from a private South Dakota herd in 1989.  
In another example of international movement 
of CWD, the disease was diagnosed in captive 
elk in Korea that reportedly had been imported 
from Saskatchewan.  It was announced in early 
2002 that one infected captive elk herd had been 
found in Alberta, and an epidemiological 
investigation is underway.  CWD is a reportable 
disease under Canada's federal Health of 
Animals Act, and the Canada Food Inspection 
Agency  has responsibility for controlling the 
disease.  Nearly 8,000 captive elk in 
Saskatchewan have been destroyed in 
eradication efforts to date at a cost of more than 
$19,000,000 for indemnification and cleanup. 
 
In 1997, South Dakota became the first state to 
detect CWD within the commercial elk industry.  
As of May 2002, CWD has been diagnosed in 
20 privately owned elk herds in Colorado (7), 
South Dakota (7) Kansas (1), Montana (1), 
Nebraska (3), and Oklahoma (1).  
Epidemiological investigations have disclosed 
animal movement among some of the infected 
elk ranches.  A group of interconnected facilities 
near Rapid City, South Dakota, that experienced 
particularly severe infection appeared to be the 
original source of CWD for other South Dakota 
game farms.  Additional investigations have 
revealed that two herds of the infected elk in 
Nebraska originated in Colorado, infected elk in 
Oklahoma apparently originated in Montana, 
and CWD subsequently was confirmed in the 
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Colorado and Montana source herds.  In late 
2001, CWD was found in captive elk shipped 
from an infected Colorado elk ranch to two 
herds in Colorado and one herd in Kansas.  Over 
the course of several years, exposed animals 
from the source herd in Colorado had been 
shipped to captive elk operations in 19 states as 
well as to more than 40 other commercial 
facilities in Colorado.  The other living elk 
shipped from this facility have been traced, 
euthanized, and tested for CWD with negative 
results. 
 
All but two of the infected captive herds found 
in the United States have been depopulated.  
One Nebraska herd was quarantined, monitored 
for additional cases of CWD, and released from 
quarantine after no more cases were found in 3 
years.  The Oklahoma herd has not been 
depopulated despite the recognition of infected 
elk in 1998, but it recently was appraised in 
preparation for euthanasia, testing, and disposal 
of the animals.  As is the case with the 
Oklahoma herd, there are other situations where 
there was an extended delay between the 
diagnosis of CWD and herd depopulation.  In 
several instances this delay occurred while 
arrangements were made with state and federal 
animal health authorities for compensation of 
the owner. 
 
Indemnification for captive elk destroyed in 
CWD control efforts is one component of the 
proposed program currently being developed by 
USDA's Animal and Plant Health Inspection 
Service (APHIS).  The APHIS program, which 
was requested by the commercial elk industry, is 
being put together with their assistance as well 
as with input from animal health officials, 
wildlife management agencies, and other 
organizations.  Drafts of the proposed program 
have been informally reviewed, and a formal 
document is being prepared for publication in 
the Federal Register.  The major components of 
the program are indemnification for elk 
destroyed in CWD-control efforts, a monitoring 
and certification program for captive elk herds, 
and for herd plan guidelines for positive 
facilities.  The programs as currently proposed 
would be voluntary unless interstate shipment of 
animals is involved and will apply only to 
captive elk with no provisions for other cervid 
species. 
 
In September 2001, the USDA issued a 
declaration of emergency regarding CWD, and 
approximately $2.6 million were made available 
in Commodity Credit Corporation (CCC) funds 
for indemnification and surveillance.  In 
February 2002, an Interim Rule was published 
in the Federal Register regarding CWD 
indemnification and another $12.2 million in 
CCC funds were released to support CWD 
control efforts.  In addition to compensating 
owners for the destruction of positive or 
exposed cervids, the USDA recently purchased 
approximately 1,350 elk in the northeastern 
portion of Colorado where CWD is endemic in 
wild deer and elk.  Owners of nearly all of the 
captive elk herds in the endemic area 
participated in this buyout and agreed to never 
restock their property with cervids because of 
the continued disease risk.  There will be no 
new captive cervid facilities constructed in 
Colorado's endemic area.  Requests for similar 
federal assistance are expected from other states 
that recently have found CWD in wild animals.  
 
Individual states may implement more stringent 
regulations than are outlined in the proposed 
federal CWD control program.  In response to 
the identification of CWD in captive and wild 
cervids in several locations, numerous states 
recently have imposed bans or stringent 
regulations on live cervid movement.  In some 
states, these regulations apply to animals 
originating from areas where CWD has been 
detected, while in others there is total 
prohibition of live cervid importation.  
Additionally, some states now require 
mandatory CWD surveillance of captive deer 
and elk.  (Prepared by John Fischer) 
 
Additional sources of information: 
 
Canadian Food Inspection Agency 
(www.inspection.gc.ca) 
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USDA's Animal and Plant Health Inspection 
Service (www.aphis.usda.gov) 
 
CWD in Wild Deer and Elk 
 
In recent years, wildlife agencies in numerous 
states and Canadian provinces have worked 
diligently to identify the distribution and 
prevalence of CWD in wild deer and elk.  This 
surveillance has resulted in the discovery of 
several new foci of CWD among wild cervids 
since 2000.  This report summarizes the 
circumstances of occurrence and detection of 
CWD in wild deer and elk as of late May 2002.   
 
Endemic area in Colorado, Wyoming, and 
Nebraska:  In 1981, CWD was diagnosed for the 
first time in clinically ill free-ranging elk in 
northeastern Colorado.  Later, clinically affected 
wild elk were found in adjacent southeastern 
Wyoming.  By 1990, wild mule deer and white-
tailed deer with CWD had been found in the 
same regions of both states.  Initially, the 
detection of CWD in these two states resulted 
from submission of clinically affected animals 
for diagnosis.  Additionally, active surveillance 
programs conducted by the Colorado Division 
of Wildlife and the Wyoming Game and Fish 
Department were developed in which hunter-
killed, road-killed, or culled deer and elk were 
tested for CWD.  This combination of targeted 
and active surveillance provided the information 
that allowed delineation of the CWD-endemic 
focus within Colorado and Wyoming.  During 
2000, active surveillance of hunter-killed deer in 
the adjacent southwestern corner of Nebraska 
disclosed an infected mule deer in Kimball 
County.  Further active surveillance in 2001 has 
disclosed two additional infected deer in 
Kimball County and one in Cheyenne County.  
In early 2002, the Nebraska Game and Parks 
Commission (NGPC) announced that a 
clinically affected deer had tested positive for 
CWD in Scotts Bluff County, two counties to 
the north of Kimball County on Nebraska's 
western border.  Prevalence of infection in the 
Colorado and Wyoming portions of this 
endemic focus has been estimated at less than 
1% for elk, about 5% for mule deer, and about 
2% for white-tailed deer.  Local prevalence 
varied widely, however, and some 
subpopulations of mule deer had prevalences of 
15%.   
 
Saskatchewan:  In Saskatchewan, CWD first 
was detected in 2000 in a mule deer killed by a 
hunter near the Alberta border.  This animal was 
tested as part of active surveillance of 
approximately 1,400 hunter-harvested deer and 
elk following confirmation of CWD in more 
than 30 captive elk herds in Saskatchewan.  
Subsequent active surveillance conducted by 
Saskatchewan Environment and Resource 
Management personnel disclosed a second 
positive mule deer within the same general area.  
Although the source of infection in these wild 
animals is unknown, it is regarded as a possible 
spillover from infected farmed elk.  Herd 
reduction efforts are underway in an effort to 
control the spread of CWD in wild cervids.  
Active province-wide surveillance of more than 
4,000 hunter-killed wild deer and elk in the fall 
of 2001 yielded uniformly negative results.   
 
Northwestern Nebraska: In 2001, active 
surveillance in the vicinity of a CWD-positive 
captive elk herd in Sioux County disclosed 
several infected white-tailed deer.  On the ranch 
with the positive elk, a CWD infection rate of 
approximately  50% was found among 179 wild 
deer inside a high fence enclosure built on the 
property at the time the elk enclosure was 
constructed in the early 1990s.  Among the 
positive deer were four fawns approximately 8-
months old.  Within a radius of 5 miles 
surrounding the property, 7 of 103 deer (6.8%) 
were CWD positive, and this prevalence 
dropped to 3.5% among 57 deer tested in the 
zone between 5 and 10 miles from the property.  
Of 125 deer tested between 10 and 20 miles 
from the facility, a single positive animal was 
found at a distance of 11 miles.  The Nebraska 
Game and Parks Commission (NGPC) 
continues to monitor this focus of infection and 
has implemented an aggressive disease 
management plan to prevent the spread of CWD 
throughout the state's wild deer. 
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Southwestern South Dakota:  The South Dakota 
Department of Game, Fish, and Parks began 
active surveillance for CWD after several 
positive captive elk herds were identified in 
1997-1998.  In 1998, a single positive white-
tailed deer was found among 30 formerly wild 
deer that had been enclosed within one of the 
private elk facilities.  From 1997-1999, positive 
free-ranging animals were not detected among 
approximately 1,000 deer and elk tested 
throughout the state.  Sampling did not occur in 
2000; however, 1 positive deer was found 
among approximately 500 hunter-killed deer 
and elk tested in 2001.  The positive animal was 
from Fall River County in southwestern South 
Dakota near the Nebraska border.  The animal 
was harvested in the area where CWD 
previously had occurred in captive elk herds as 
well as within 50 miles of the northwestern 
Nebraska captive elk facility where CWD had 
been diagnosed in captive and wild cervids.  
Active surveillance has been conducted in the 
vicinity where the positive South Dakota deer 
was found as well as in the intervening area 
between this location and the affected area in 
northwestern Nebraska. To date, additional 
positive animals have not been found. 
 
Western Slope of Colorado:  In March 2002 the 
Colorado Division of Wildlife (CDOW) 
announced it had confirmed CWD infection for 
the first time in mule deer west of the 
continental divide in Routt County, Colorado.  
In accordance with CDOW policy, wild deer 
and elk that had been inadvertently confined 
with captive-bred elk in a facility constructed in 
the summer of 2001 were destroyed in order to 
prevent them from escaping back into the wild.  
Two deer of 340 entrapped wild deer and elk 
killed in the enclosure tested positive for CWD.  
From April 1-3, 2002, personnel from CDOW 
and USDA-APHIS' Wildlife Services collected 
308 wild deer within a 5-mile radius outside the 
private facility.  Two deer collected during this 
operation tested positive for CWD, and 1 more 
infected deer was found among 18 deer 
subsequently killed in the same immediate area.  
Beginning April 15, 2002, an additional 135 elk 
and 285 deer were killed within 5 miles of the 
private enclosure in an aggressive attempt to kill 
as many wild deer and elk as possible before the 
animals began seasonal migration out of the 
area.  This task was carried out by CDOW and 
Wildlife Services personnel, assisted by 
volunteers from the Mule Deer Association, 
Rocky Mountain Elk Foundation, Traditional 
Bowhunters Association, Colorado Outfitters 
Association, and Colorado Bowhunters 
Association.  None of the elk tested positive, but 
three more positive deer were identified.  This 
brings the total number of positive deer outside 
the facility to 6 of 633 killed and tested, 
indicating a prevalence of less than 1% in the 
wild deer in the area.  The source of this focus 
has yet to be determined.  Since 1996, CDOW 
has tested more than 2,000 animals throughout 
the non-endemic portion of the state for CWD, 
including animals from each of the large mule 
deer herds on the Western Slope.  None has 
been infected, with the exception of the recent 
Routt County outbreak.   
 
Wisconsin:  The Wisconsin Department of 
Natural Resources (DNR) began active 
surveillance of hunter-killed white-tailed deer in 
1999 and through the 2001 hunting season had 
sampled more than 1,000 deer.  On February 28, 
2002, it was announced that three deer, all 
harvested within 2 miles of each other in Deer 
Management Unit (DMU) 70A in Dane County 
in 2001, were CWD positive by 
immunohistochemistry assay of brain stem.  
One deer was emaciated and lethargic when 
shot by the hunter.  Subsequent collection and 
testing of 516 deer within a 5-mile radius 
centered around the positive animals disclosed 
an additional 15 (2.9%) infected animals during 
March-April 2002.  The origin of this focus of 
CWD is not yet clear, but the absence of any 
positive deer in other DMUs argues against the 
concept of a long-term, naturally occurring 
enzootic presence in the state.  In response to 
this crisis, the Wisconsin DNR currently is 
developing and implementing an aggressive 
disease management program to kill as many 
deer as possible within a 328-square-mile area.  
In one component of the program, landowners 
will be authorized to shoot deer on their 
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property in the "Chronic Wasting Disease 
Eradication Zone" for 1 week per month during 
June, July, August, and September.  Thousands 
of wild whitetails are targeted for depopulation 
in this effort to prevent CWD’s spread 
throughout Wisconsin's deer herd. (Prepared by 
Randy Davidson) 
 
Additional sources of information: 
 
Colorado Department of Wildlife 
(www.wildife.state.co.us) 
 
Nebraska Game and Parks Department  
(www.ngpc.state.ne.us/wildlife/cwd/cwdinfo.ht
ml) 
 
Saskatchewan Environment and Resource 
Management (www.serm.gov.sk.ca) 
 
South Dakota Game, Fish and Parks 
(www.state.sd.us/gfp/) 
 
Wisconsin Department of Natural Resources 
(www.dnr.state.wi.us) 
 
Wyoming Game and Fish (gf.state.wy.us) 
 
Public Health Concerns About CWD 
 
There currently is no convincing evidence that 
the agent of chronic wasting disease (CWD) 
affects humans.  However, public health 
officials recommend that human exposure to the 
CWD agent be avoided as they continue to 
evaluate any potential risk.  Contrary to a story 
that circulated in the popular press, an 
investigation by the Centers for Disease Control 
and Prevention (CDC) did not find a link 
between CWD and Creutzfeldt-Jakob Disease 
(CJD) in three persons, aged 28-30 years, who 
consumed venison.  The investigators 
concluded: "Although the occurrence of 3 
unusually young patients with CJD who 
consumed venison suggested a possible 
relationship with CWD, our follow-up 
investigation found no strong evidence for a 
causal link.  Ongoing CJD surveillance remains 
important for continuing to assess the risk, if 
any, of CWD transmission to humans."  
 
The tendency toward a natural “species barrier” 
reducing human susceptibility to CWD and 
other prion diseases has been demonstrated by 
in vitro studies.  However, lingering uncertainty 
about any potential risk that CWD may pose to 
humans is fostered by differing experiences with 
two more common animal TSEs.  Although 
there is a long history of human exposure to 
scrapie through handling and consuming sheep 
tissues, including brain, there is no evidence that 
scrapie presents a risk to human health.  In 
contrast, massive exposure of British and 
perhaps other European citizens to the BSE 
agent has resulted in approximately 130 human 
cases of variant CJD as of April 2002.  In 2000, 
the World Health Organization (WHO) 
published the proceedings of the WHO 
Consultation on Public Health and Animal 
Transmissible Spongiform Encephalopathies:  
Epidemiology, Risk and Research Requirement.  
The consultants consisted of researchers from 
around the world who are experts on human and 
animal spongiform encephalopathies.  The 
consultants summarized their findings with the 
statement:  "There currently is no evidence that 
Chronic Wasting Disease in Cervidae is 
transmitted to humans."   
 
This situation has not changed.  Despite the lack 
of a causal link between CWD in deer and elk 
and CJD in humans, the WHO Consultation 
made the following recommendations regarding 
CWD:  Authorities should encourage awareness 
and surveillance for CWD around the world; no 
part or product of any animals with evidence of 
CWD or other TSEs should be fed to humans or 
any species of domestic or captive animal; work 
should continue to improve the understanding of 
CWD; and precaution should be taken to 
prevent introduction and spread of CWD when 
translocating wild or domestic cervids.  
 
Similarly, public health and wildlife 
management professionals encourage hunters, 
meat processors, and taxidermists to take some 
common sense measures to prevent potential 
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exposure to the CWD agent and to other known 
zoonotic pathogens.  For example, the Colorado 
Division of Wildlife recommends the following 
precautions for hunters in the CWD endemic 
area:  Do not shoot, handle or consume any 
animal that appears sick; contact the Division of 
Wildlife if you see or harvest an animal that 
appears sick.  
· Wear rubber gloves when field dressing 
carcasses. 
· Bone out the meat from your animal.  
· Minimize the handling of brain and spinal 
tissues.  
· Wash hands and instruments thoroughly after 
field dressing is completed. 
· Avoid consuming brain, spinal cord, eyes, 
spleen, tonsils, and lymph nodes of harvested 
animals.  
· Avoid consuming the meat from any animal 
that tests positive for the disease.  
· Request that your animal be processed 
individually, without meat from other 
animals being added to meat from your 
animal.   
(Prepared by John Fischer) 
 
Additional Sources of Information: 
 
Belay, Ermias D. et al.  2001.  Creutzfeldt-Jakob 
Disease in unusually young patients who 
consumed venison.  Archives of Neurology 
58:1673-1678. 
 
Williams, Elizabeth S., Michael W. Miller, and 
E. Tom Thorne.  Chronic Wasting Disease:  
Implications and Challenges for Wildlife 
Managers.  Transactions of the 67th North 
American Wildlife and Natural Resources 
Conference.  In Press. 
 
Centers for Disease Control and Prevention 
(www.cdc.gov) 
 
Colorado Division of Wildlife 
(www.wildlife.state.co.us) 
 
World Health Organization (www.who.int) 
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Mailing List Update 
If you are receiving the SCWDS BRIEFS through forwarding from an old address or you are reading 
someone else’s copy and want to receive your own, please let us know.  Also, if you know someone else 
who would appreciate receiving the BRIEFS, have them notify us.  You can send the information to 
dwood@vet.uga.edu  or fill out the form below. 
 
NAME_______________________________________________ 
ORGANIZATION_______________________________________ 
ADDRESS____________________________________________ 
CITY, STATE, ZIP______________________________________ 
 
MAIL TO:  
Gary Doster 
Southeastern Cooperative Wildlife Disease Study 
College of Veterinary Medicine 
University of Georgia 
Athens, GA 30602 
 
 
 
 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
Information presented in this Newsletter is not intended for citation in 
scientific literature.  Please contact the Southeastern Cooperative 
Wildlife Disease Study if citable information is needed. 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
 
Recent back issues of SCWDS BRIEFS can be accessed on the Internet at SCWDS.org. 
